Abstract
The article by Douglas Figg in this issue1 addresses two important questions in clinical medicine and clinical research. First, how should the United States respond to the growing shortage of clinical pharmacologists who have traditionally fulfilled key roles in patient care, drug development research, and drug policy? Second, how can doctor of pharmacy (PharmD) graduates be prepared for postgraduate education in a manner that allows them to effectively contribute to these three critical areas as health-care practice and research become increasingly interdisciplinary? Clinical Pharmacology & Therapeutics (2008); 84, 4, 445–447 doi:10.1038/sj.clpt.6100475
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
